Carcinoma
Conditions
Keywords
Breast cancer, Ovarian cancer, Lung cancer, Colon cancer, Gastric cancer, Pancreatic cancer, Rectum cancer, Plasmacytoma
Brief summary
The purpose of this registry is to evaluate the situation regarding ambulant therapy of cancer patients in different practices in Germany. It should provide insight into the implementation of schemes for cancer therapy predefined in the guidelines, the treatment of diverse adverse reactions and the counter measures taken. Thereby, potential differences in treatment and with that differences in quality amongst individual practices might be identified. The medium to long term aim is to contribute to positively influence the quality of medical care of cancer patients in Germany.
Interventions
None listed
Sponsors
AKP Freiburg GmbH
SPGO Research Mannheim GmbH
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 years and older * Tumor disease (carcinoma of either breast, ovary, lung, colon, stomach, pancreas, rectum or plasmacytoma) * Written informed consent
Exclusion criteria
none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Anti-cancer treatments (Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation) | From date of ICF until date of cure/death/ICF withdrawal, up to 60 months | Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adverse reactions and their treatment (Number and type of adverse reactions and applied counter measures / therapies) | From date of ICF until date of cure/death/ICF withdrawal, up to 60 months | Number and type of adverse reactions and applied counter measures / therapies |
Countries
Germany
Contacts
Primary ContactHilde Huber
Outcome results
None listed